EU PERSPECTIVES - The European Union may have built the world's most ambitious health data framework with the European Health Data Space, but it has overlooked one crucial element: citizens. While Brussels focuses on rules and infrastructure, Europeans are already seeking health advice from American AI platforms, filling a gap the EU has yet...
EURACTIV - More than a third of LGBTIQ+ people in the EU report discrimination, and over half face harassment, yet political backlash and budget cuts are threatening to reverse a decade of progress. Juliane Marie Neiiendam, a member of the Civil Society Organisations' Group of the EESC and Vice-President for Equality, tells Euractiv why the bloc's...
EU PERSPECTIVES - Funding that helps fight cancer, rare diseases or future health crises could lose its own programme in the next EU budget. The European Commission wants to fold it into a new competitiveness fund. MEPs warn health spending could become harder to track among defence, tech and industry — and easier to sideline when priorities clash....
EU PERSPECTIVES - Life sciences model in Europe is a broken 'societal agreement', says Tomer Feffer of the pharmaceutical company Bayer. Companies take on long-term risk and investment with no guarantee of success — only to face delayed access, price erosion and regulatory complexity once a treatment is ready. Read more
EU PERSPECTIVES - Fifty million Europeans still cannot access cancer therapies that deliver radiation directly to tumour cells. The EU is failing to change that. Radioligand therapies are currently a last resort for patients with the most advanced disease. Millions across the EU still cannot reach them. MEP Nikos Papandreou (S&D/GRC) is pushing the...
EURACTIV - Bayer's Benelux head, Niels Hessmann, says Europe has the potential to lead the next wave of biotech innovation. The company is pouring billions into a "third wave" of therapies that aim not just to treat symptoms but to stop or even reverse disease. Read more
EU PERSPECTIVES - Health will not be squeezed in the EU's next long-term budget. It is poised to come out stronger, Health Commissioner Olivér Várhelyi told EU Perspectives in an exclusive interview. He is moving to reposition health from a protected spending line to a core driver of Europe's competitiveness. Read more
EU PERSPECTIVES - Shampoos, lipsticks and other everyday cosmetics could remain on the EU market containing controversial 'forever chemicals' for years under proposed simplification rules. Lawmakers split over how far Europe should go in easing restrictions on substances linked to cancer and other serious health risks in the name of cutting red...
EU PERSPECTIVES - Medical devices are disappearing from the European market — not over safety concerns, but paperwork. Brussels now wants to overhaul the system and turn medtech into its main trump card in the global AI race. The reform promises approvals three times faster and savings of over €3bn a year. Read more
EURACTIV - Belgium is moving to establish radioligand therapy as an integral pillar of cancer care. But early rollout has exposed a widening gap between breakthrough innovation and the system's ability to deliver it at scale. Expectations are now high for the new cancer plan expected this year, where stakeholders hope radioligand therapy will be...